News for 'kv-pharmaceutical'

Strides Arcolab terminates agreement with US firm

Due to the developments at KV, like recall of their products, regulatory actions, filing of a series of class actions by shareholders the company has terminated the 'License and Supply Agreement', Strides Arcolab said in a filing to the Bombay Stock Exchange.